| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net income | 89,677 | 47,466 |
| Depreciation and amortization | 15,329 | 7,666 |
| Loss on disposal of property and equipment | -131 | 0 |
| Deferred and other income taxes | 23,211 | 5,827 |
| Amortization of debt origination costs | 889 | 442 |
| Stock-based compensation costs | 5,449 | 3,682 |
| Non-cash operating lease cost | 3,879 | 1,947 |
| Accounts receivable | 2,580 | -27,343 |
| Inventories | 10,277 | 4,441 |
| Prepaid expenses and other current assets | 11,767 | 10,946 |
| Accounts payable | 22,545 | 2,756 |
| Accrued liabilities | 3,923 | -813 |
| Operating lease liabilities | -3,839 | -1,916 |
| Other | 71 | 0 |
| Net cash provided by operating activities | 136,499 | 79,013 |
| Purchases of property, plant and equipment | 2,940 | 838 |
| Other | 1,927 | 1,100 |
| Net cash (used in) investing activities | -4,867 | -1,938 |
| Term loan repayments | 0 | 0 |
| Payments of finance leases | 1,147 | 608 |
| Proceeds from exercise of stock options | 3,907 | 3,155 |
| Fair value of shares surrendered as payment of tax withholding | 4,216 | 4,054 |
| Repurchase of common stock | 109,775 | 34,775 |
| Net cash (used in) financing activities | -111,231 | -36,282 |
| Effects of exchange rate changes on cash and cash equivalents | 821 | 825 |
| Increase in cash and cash equivalents | 21,222 | 41,618 |
| Cash and cash equivalents at beginning of period | 97,884 | - |
| Cash and cash equivalents at end of period | 119,106 | - |
Prestige Consumer Healthcare Inc. (PBH)
Prestige Consumer Healthcare Inc. (PBH)